DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20214474

Rational use and cost variation analysis of antitussive-expectorants available in the Indian market: a pharmacoeconomic study

Pramod Kumar Manjhi, Sunil Kumar Singh, Chakrapani Kumar, Akhilesh Kumar Rana

Abstract


Background: Antitussive-expectorants are among the most frequently prescribed drugs by physicians in clinical practice. Upper respiratory tract infections, such as common cold, acute pharyngitis and acute trachea-bronchitis, are the most common of all communicable diseases and significantly increase OPD burden. This study aimed to assess the rational use, cost ratio, and percentage cost variations in different brands of the commonly prescribed antitussive-expectorants available in the Indian market.

Methods: The cost of antitussive-expectorant manufactured by different pharmaceutical companies was obtained by using drug today Jan-April 2021 vol 2. The maximum and minimum price was noted down, cost ratio and percentage cost variation of the individual formulation were analysed.  

Results: Analysis of cost ratio and percentage cost variation for each formulation of the antitussive-expectorants drug, syrup (100 ml) chlorpheniramine (2 mg), dextromethorphan (10 mg), phenylephrine (5 mg) combinations show the highest cost ratio and percentage cost variation as 5.30 and 430.25 respectively, and syrup (100 ml) dextromethorphan (10 mg), guaifenesin (100 mg), phenylephrine (25 mg), chlorpheniramine (4 mg) combinations show lowest cost ratio and percentage cost variation as 1.17 and 17.69 respectively.

Conclusions: There was a wide variation in the cost of different brands of antitussive-expectorant drugs available in the Indian market. So, clinicians should be aware of rational use and variations in cost to reduce the treatment cost and increase patient compliance.


Keywords


Pharmacoeconomics, Cost ratio, Cost variation, Antitussive-expectorants

Full Text:

PDF

References


World Health Organization. The rational use of drugs. Report of the conference of experts. Geneva: World Health Organization; 1985. Available at: http://www.apps.who.int/medicinedocs/en/m/abstract/Js17054e/ Accessed on 13 November 2021.

Holloway K, Dijk VL. Rational Use of Medicines World Medicines Situation Report. World Health Organization; 2011. Report No. WHO/EMP/MIE/2011.2.2. Available at: http://www. who.int/medicines/areas/policy/world_medicines_situation/WMS_ch14_wRational Accessed on 13 November 2021.

World Health Organization- Country Office for India. Promoting Rational Drug Use under NRHM, 2009. Available at: http://hsrii.org/wpcontent/uploads/2014/05/Promoting_Rational_Drug_use_under_NRHM_NHSRC_WHO1 Accessed on 13 November 2021.

Tripathi KD. Essentials of Medical Pharmacology. Jaypee publishers New Delhi, 8th Ed. 2018;227-8.

Gibson PG, Simpson JL, Ryan NM. Mechanisms of cough. Curr Opin Allergy Clin Immunol. 2014;14:55-61.

Munyard P, Bush A. How much coughing is normal? Arch Dis Child. 1996;74:531-4.

Chang AB, Glomb WB. Guidelines for evaluating chronic cough in pediatrics: ACCP evidence-based clinical practice guidelines. Chest. 2006;129:260S-83.

Galway NC, Shields MD. The child with an incessant dry cough. Paediatr Respir Rev. 2019;30:58-64.

Gilchrist FJ. An approach to the child with a wet cough. Paediatr Respir Rev. 2019;31:75-81.

Morice A, Kardos P. Comprehensive evidence-based review on European antitussives. BMJ Open Resp Res. 2016;3:e000137.

Cohen HA, Rozen J, Kristal H. Effect of honey on nocturnal cough and sleep quality: a double-blind, randomized, placebo-controlled study. Pediatrics. 2012;130:465-71.

Hay AD, Wilson A, Fahey T. The duration of acute cough in pre-school children presenting to primary care: a prospective cohort study. Fam Pract 2003;20:6.

Morice AH, McGarvey L, Pavord I. Recommendations for the management of cough in adults. Thorax. 2006;61(1):1-24.

Thompson M, Vodicka TA, Blair PS. Duration of symptoms of respiratory tract infections in children: systematic review. BMJ. 2013;347:f7027.

National Institute for Health and Care Excellence. Cough (acute): antimicrobial prescribing. NICE guideline. London: NICE National Institute for Health and Care Excellence. 2019.

Rimsza ME, Newberry S. Unexpected infant deaths associated with use of cough and cold medications. Pediatrics. 2008;122:e318-22.

Srivastava SK. Medical Pharmacology. Avichal publishing company, New Delhi, 2nd Ed. 2017;438.

Eaddy MT, Cook CL, O’Day K, Burch SP, Cantrell CR. How patients cost-sharing trends affects adherence and out comes: a literature review. PT. 2012;37(1):45-55.

Hecht A. The common cold: relief but no cure. Available at: http//www.hoptechno.com/book64htm. Accessed on May 20, 2021.

Simasek M, Blandino DA. Treatment of the common cold. Am Fam Physician. 2007;75:515-20.

Schroeder K, Fahey T. Over the counter medication for acute cough in children and adult in ambulatory setting. Cochrane database Syst Rev. 2004;18:CD001831.

West S, Brandon B, Stolley P, Rumrill R. A review of antihistamines and the common cold Pediatrics. 1975;56:100-7.

Hussein SH. cough mixtures. 1996. Available at: http://www.prn2.usm.my/mainsite/bulletin/sun/1996/sun39.html. Accessed on May 20, 2021.

Thomas M. Rational drug use and essential drug concept. In: Parthasarthi G, Nyfort Hasen K, eds. A textbook of clinical pharmacy practice. 1st ed. Hyderabad: Orient Longman. 2004;723.

Drug Cost Control. Government of India, 2013. Available at: http://www.nppaindia.nic.in/ DPCO2013. Accessed on 13 November 2021.

Vieira JL, Portal VL, Moriguchi EH. How much do we pay for a benefit? The need for a national cost-effectiveness analysis. Arq Bras Cardiol. 2001;76(5):409-18.